Vialwirebiotech, curated
November 21, 2026, 7:14 AM
October 28, 2026
- 7:29 AM · FT — Pharmaceuticals7:29 AMGSK shares slide after weaker vaccine sales — FT — Pharmaceuticals
- 7:00 AM · Drug Discovery World7:00 AMTrial data presented at ESMO support cancer microbiome therapy — Drug Discovery World
- 6:29 AM · Pharmaceutical Technology6:29 AMAnthropic plots IPO amid ongoing foray into drug development — Pharmaceutical Technology
- 5:57 AM · Pharmaceutical Technology5:57 AMFDA grants orphan drug status to Octant’s OCT-980 for RP — Pharmaceutical Technology
- 5:50 AM · Pharmaceutical Technology5:50 AMArrowhead gains UK marketing authorisation for Redemplo — Pharmaceutical Technology
October 27, 2026
- 8:43 PM · Pharmaceutical Technology8:43 PMESMO26: Standard dosing prevails over 12-week checkpoint inhibitors in MOIO trial — Pharmaceutical Technology
- 4:00 PM · Nikkei Asia4:00 PMTakeda debuts narcolepsy drug targeting root cause, capping 15-year effort — Nikkei Asia
- 2:45 PM · STAT News
- 12:03 PM · BioPharma Dive12:03 PMCourt rejects Novo bid to block Lilly obesity drug ads — BioPharma Dive
- 12:00 PM · BioWorld12:00 PMDaiichi ADC up a tree? Macrogenics’ could be TOP1 in HN — BioWorld
- 12:00 PM · BioWorld12:00 PMRing vaccination trial underway at heart of Bundibugyo outbreak — BioWorld
- 12:00 PM · BioWorld12:00 PMChina approves Bayer's asundexian in world-first for FXIa — BioWorld
- 12:00 PM · BioWorld12:00 PMJapan backs Nipro’s Stemirac for first full approval under CEA — BioWorld
- 12:00 PM · BioWorld12:00 PMNovartis takes $1.9B impairment after Avidity's phase III failure — BioWorld
- 12:00 PM · BioWorld12:00 PMGilead expands in I&I with $1.28B Pepstar deal for oral IL-23Ri — BioWorld
- 12:00 PM · BioWorld12:00 PMFerring expands women’s health franchise with $1.4B Gameto buy — BioWorld
- 11:44 AM · BioPharma Dive11:44 AMArtiva to quit autoimmune cell therapy work, cut staff after patient deaths — BioPharma Dive
- 10:28 AM · STAT News10:28 AMSTAT+: Nonprofit resurrects shelved gene therapy after startup shuts down — STAT News
- 10:20 AM · Pharmaceutical Technology10:20 AMESMO26: KEYNOTE-C93 backs chemo-free Keytruda in dMMR endometrial cancer — Pharmaceutical Technology
- 9:00 AM · BioWorld9:00 AMPatronus Biotech’s malaria vaccines set for clinic in Australia — BioWorld
- 9:00 AM · BioWorld9:00 AMGNTI-148 enables durable allogeneic Treg therapy — BioWorld
- 9:00 AM · BioWorld9:00 AMADX-038 shows sustained alternative complement inhibition — BioWorld
- 9:00 AM · BioWorld9:00 AMMedicenna’s MDNA-209 extends survival in GVHD models — BioWorld
- 8:58 AM · Pharmaceutical Technology8:58 AMESMO26: Sac-TMT sets survival benchmark in recurrent endometrial cancer — Pharmaceutical Technology
- 8:00 AM · Drug Discovery World8:00 AMPositive Phase I results for long-acting anti-TL1A antibody — Drug Discovery World
- 8:00 AM · BioWorld8:00 AMRegulatory: Fast track designations for Samsung Bioepis, Ultragreen.ai — BioWorld
- 8:00 AM · BioWorld8:00 AMFinancings: Zai Lab raises $250M — BioWorld
- 8:00 AM · BioWorld8:00 AMA&As: New CSL CEO; Transcenta names CFO — BioWorld
- 8:00 AM · BioWorld8:00 AMDeals/M&As: ADC collaborations; Nxera-Synmosa pact for Quviviq — BioWorld
- 8:00 AM · BioWorld8:00 AMClinics: Taimed HIV data and more — BioWorld
- 7:34 AM · Pharmaceutical Technology7:34 AMPfizer’s prostate cancer combo moves to earlier line on expanded US approval — Pharmaceutical Technology
- 7:30 AM · SCMP — Tech7:30 AMChina’s Hengrui posts 89% rise in third-quarter net profit, beating estimates — SCMP — Tech
- 5:54 AM · Pharmaceutical Technology5:54 AMRegeneron agrees to $270m extension to supply Ebola medicine in US — Pharmaceutical Technology
- 5:35 AM · Pharmaceutical Technology5:35 AMChina’s NMPA accepts Innovent application for sintilimab combo — Pharmaceutical Technology
- 5:00 AM · Labiotech (EU)5:00 AMThe stranded asset problem in microbial custom manufacturing — Labiotech (EU)
- 2:00 AM · SCMP — Tech2:00 AMChina trial shows gum tissue stem cells help 55% of lifetime diabetes patients — SCMP — Tech
- 1:00 AM · FT — Pharmaceuticals1:00 AMCan French drugmaker Sanofi fix its pipeline? — FT — Pharmaceuticals
October 26, 2026
- 7:17 PM · STAT News7:17 PMSTAT+: Roche gets a lung cancer win with its KRAS drug divarasib — STAT News
- 3:17 PM · BioPharma Dive3:17 PMCorxel, an obesity drugmaker, to go public via SPAC deal — BioPharma Dive
- 12:20 PM · STAT News12:20 PMSTAT+: GSK sees its return to cancer starting to pay off — STAT News
- 12:06 PM · BioPharma Dive12:06 PMBioNTech, DualityBio say ADC had ‘modest’ benefit in breast cancer study — BioPharma Dive
- 12:00 PM · BioWorld12:00 PMSet for RCC glory? Hard phase I data ‘cement’ Xencor — BioWorld
- 12:00 PM · BioWorld12:00 PMAcuity annuity? Eyes on Stargardt news stream ahead — BioWorld
- 11:52 AM · Pharmaceutical Technology11:52 AMESMO26: SANOVO data backs 1L Orpathys use in NSCLC subgroup, but AEs temper reaction — Pharmaceutical Technology
- 11:30 AM · STAT News
- 9:57 AM · STAT News
- 9:38 AM · Pharmaceutical Executive9:38 AM<![CDATA[ Pathos Ai Enters Drug Development Collaboration with Bristol Myers Squibb and Tempus Ai ]]> — Pharmaceutical Executive
- 9:04 AM · SCMP — Tech9:04 AMChinese biotech giant WuXi AppTec raises 2026 outlook after profit surge — SCMP — Tech
- 9:00 AM · BioWorld9:00 AMAscletis files IND for selective amylin receptor agonist ASC-39 — BioWorld
- 8:54 AM · PharmaVoice8:54 AMMS has plenty of drugs. This Ocrevus veteran sees what’s missing. — PharmaVoice